Of course not. $25? I'd consider it where things s

Quote:

---

Of course not. $25? I'd consider it where things stand now

---

Where we stand now doesn't matter. BP want to see the data before any offer. We have good data we have approval for COVID-19. We have approval for COVID-19 share price should be near a $25 offer. So you would accept a bit over share price instead of waiting a short while after results are released. Then look at the potential after that.. That's some pretty short-sighted thinking.